Skip to main content

Volume 16 Supplement 3

Sepsis 2012

Erythropoietin enhances the effects of transplanted mesenchymal stem cells in an experimental model of endotoxemia

Background

Mesenchymal stem cells (MSCs) are able to reduce systemic inflammatory response in an experimental sepsis. One of the limiting factors of MSC therapy is a high degree of apoptosis of transplanted cells. On the basis of recently detected receptors for erythropoietin (EPO) on the surface of MSCs we hypothesized that introduction of EPO together with MSCs may increase survival of grafted MSCs and improve the clinical efficacy of cell transplantation.

Methods

Fifty Wistar male rats were randomized into five groups with 10 animals in each: Group 1 were healthy controls, Groups 2 to 5 were intraperitoneally introduced bacterial LPS 20 mg/kg. Two hours later LPS injection animals received the following intravenous treatment: 4 × 105 allogeneic MSCs (Group 3), 8.5 μg recombinant EPO-β (Group 4), MSCs and EPO in the same doses (Group 5). Surviving animals were euthanized on the fourth day. The morphological study, white blood cell count (WBC) and serum level of IL-1β, IL-2, IL-6, and TNFα measurement were performed.

Results

The highest WBC was found in the group of combined treatment EPO + MSCs. The serum IL-1β level in Groups 2 and 4 was significantly higher than in healthy and treated with MSCs and EPO + MSCs animals. The main results of the morphologic analysis of different tissues in the groups are presented in Table 1. The most significant differences in the LPS + EPO group were found in the lymphoid tissue - considerable hyperplasia of spleen white pulp and thymus cortex (Figure 1).

Table 1 Morphometric characteristics of the examined tissues in the experimental groups
Figure 1
figure 1

Representative hematoxylin and eosin staining of thymus tissue 96 hours post LPS injection (×100).

Conclusion

Combined treatment with EPO and MSCs can reduce acute lung injury and kidney damage, cause hyperplasia of lymphoid tissue and enhance the immune response more than separate treatment in an experimental model of endotoxemia in rats.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Sorokina, A., Averyanov, A., Zabozlaev, F. et al. Erythropoietin enhances the effects of transplanted mesenchymal stem cells in an experimental model of endotoxemia. Crit Care 16 (Suppl 3), P20 (2012). https://doi.org/10.1186/cc11707

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc11707

Keywords

  • Mesenchymal Stem Cell
  • White Blood Cell Count
  • Erythropoietin
  • Acute Lung Injury
  • Lymphoid Tissue